Naxitamab Interactions
There are 311 drugs known to interact with naxitamab, along with 1 disease interaction, and 1 alcohol/food interaction. Of the total drug interactions, 48 are major, and 263 are moderate.
- View all 311 medications that may interact with naxitamab
- View naxitamab alcohol/food interactions (1)
- View naxitamab disease interactions (1)
Most frequently checked interactions
View interaction reports for naxitamab and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Amitiza (lubiprostone)
- Anoro Ellipta (umeclidinium / vilanterol)
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- Bentyl (dicyclomine)
- Breo Ellipta (fluticasone / vilanterol)
- Coricidin HBP Cold & Flu (acetaminophen / chlorpheniramine)
- Coricidin HBP Cough & Cold (chlorpheniramine / dextromethorphan)
- Flonase (fluticasone nasal)
- Flovent HFA (fluticasone)
- Fluarix Quadrivalent (influenza virus vaccine, inactivated)
- IBU (ibuprofen)
- Iron Sulfate (ferrous sulfate)
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- Mucinex DM (dextromethorphan / guaifenesin)
- Ozempic (semaglutide)
- Pepcid AC (famotidine)
- Percocet (acetaminophen / oxycodone)
- Prilosec OTC (omeprazole)
- ProAir HFA (albuterol)
- Qvar RediHaler (beclomethasone)
- Rocephin (ceftriaxone)
- Singulair (montelukast)
- Sprycel (dasatinib)
- Symbicort (budesonide / formoterol)
- Tasigna (nilotinib)
- Tradjenta (linagliptin)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
Naxitamab alcohol/food interactions
There is 1 alcohol/food interaction with naxitamab.
Naxitamab disease interactions
There is 1 disease interaction with naxitamab which include:
Report options
More about naxitamab
- naxitamab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Talvey
Talvey is used to treat relapsed or refractory multiple myeloma. Includes Talvey side effects ...
Platinol
Platinol is used for bladder cancer, blood cell transplantation, bone marrow transplantation, brain ...
Iwilfin
Iwilfin (eflornithine) is an oral ornithine decarboxylase inhibitor used to reduce the risk of ...
Oncovin
Oncovin is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Vincristine
Vincristine systemic is used for acute lymphocytic leukemia, acute myeloid leukemia, anaplastic ...
Doxorubicin
Doxorubicin systemic is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
